AngioDynamics Statistics
Total Valuation
AngioDynamics has a market cap or net worth of $427.01 million. The enterprise value is $397.16 million.
Important Dates
The last earnings date was Tuesday, January 6, 2026, before market open.
| Earnings Date | Jan 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AngioDynamics has 41.22 million shares outstanding. The number of shares has increased by 1.48% in one year.
| Current Share Class | 41.22M |
| Shares Outstanding | 41.22M |
| Shares Change (YoY) | +1.48% |
| Shares Change (QoQ) | +0.89% |
| Owned by Insiders (%) | 3.56% |
| Owned by Institutions (%) | 77.90% |
| Float | 33.50M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.39 |
| Forward PS | 1.32 |
| PB Ratio | 2.44 |
| P/TBV Ratio | 3.90 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.29 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.24, with a Debt / Equity ratio of 0.07.
| Current Ratio | 2.24 |
| Quick Ratio | 1.20 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | 4.91 |
| Debt / FCF | n/a |
| Interest Coverage | -194.99 |
Financial Efficiency
Return on equity (ROE) is -15.26% and return on invested capital (ROIC) is -13.96%.
| Return on Equity (ROE) | -15.26% |
| Return on Assets (ROA) | -4.60% |
| Return on Invested Capital (ROIC) | -13.96% |
| Return on Capital Employed (ROCE) | -10.45% |
| Weighted Average Cost of Capital (WACC) | 6.68% |
| Revenue Per Employee | $455,268 |
| Profits Per Employee | -$41,052 |
| Employee Count | 675 |
| Asset Turnover | 1.10 |
| Inventory Turnover | 2.12 |
Taxes
| Income Tax | -2,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -16.85% in the last 52 weeks. The beta is 0.47, so AngioDynamics's price volatility has been lower than the market average.
| Beta (5Y) | 0.47 |
| 52-Week Price Change | -16.85% |
| 50-Day Moving Average | 12.02 |
| 200-Day Moving Average | 10.66 |
| Relative Strength Index (RSI) | 40.46 |
| Average Volume (20 Days) | 900,955 |
Short Selling Information
The latest short interest is 2.07 million, so 5.01% of the outstanding shares have been sold short.
| Short Interest | 2.07M |
| Short Previous Month | 1.89M |
| Short % of Shares Out | 5.01% |
| Short % of Float | 6.17% |
| Short Ratio (days to cover) | 2.59 |
Income Statement
In the last 12 months, AngioDynamics had revenue of $307.31 million and -$27.71 million in losses. Loss per share was -$0.67.
| Revenue | 307.31M |
| Gross Profit | 167.72M |
| Operating Income | -20.67M |
| Pretax Income | -27.71M |
| Net Income | -27.71M |
| EBITDA | -150,000 |
| EBIT | -20.67M |
| Loss Per Share | -$0.67 |
Full Income StatementBalance Sheet
The company has $41.64 million in cash and $11.79 million in debt, with a net cash position of $29.85 million or $0.72 per share.
| Cash & Cash Equivalents | 41.64M |
| Total Debt | 11.79M |
| Net Cash | 29.85M |
| Net Cash Per Share | $0.72 |
| Equity (Book Value) | 176.33M |
| Book Value Per Share | 4.24 |
| Working Capital | 89.39M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$5.60 million and capital expenditures -$3.73 million, giving a free cash flow of -$9.33 million.
| Operating Cash Flow | -5.60M |
| Capital Expenditures | -3.73M |
| Free Cash Flow | -9.33M |
| FCF Per Share | -$0.23 |
Full Cash Flow StatementMargins
Gross margin is 54.58%, with operating and profit margins of -6.73% and -9.02%.
| Gross Margin | 54.58% |
| Operating Margin | -6.73% |
| Pretax Margin | -9.02% |
| Profit Margin | -9.02% |
| EBITDA Margin | -0.05% |
| EBIT Margin | -6.73% |
| FCF Margin | n/a |
Dividends & Yields
AngioDynamics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.48% |
| Shareholder Yield | -1.48% |
| Earnings Yield | -6.49% |
| FCF Yield | -2.18% |
Analyst Forecast
The average price target for AngioDynamics is $19.33, which is 86.58% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $19.33 |
| Price Target Difference | 86.58% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 5.79% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AngioDynamics has an Altman Z-Score of 1.63 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.63 |
| Piotroski F-Score | 4 |
